The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 11, 2018

Filed:

Aug. 30, 2012
Applicants:

Richard A. Young, Weston, MA (US);

Peter B. Rahl, Natick, MA (US);

James Bradner, Weston, MA (US);

Inventors:

Richard A. Young, Weston, MA (US);

Peter B. Rahl, Natick, MA (US);

James Bradner, Weston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); A61K 38/02 (2006.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01); A61K 31/7105 (2006.01); A61K 31/551 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/02 (2013.01); A61K 31/551 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); C07K 16/00 (2013.01); G01N 33/5011 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01);
Abstract

Disclosed herein are methods and compositions useful for inhibiting interaction between a bromodomain protein and an immunoglobulin (Ig) regulatory element. The methods and compositions are particularly useful for downregulating expression of an oncogene translocated with an Ig locus, as well as for treating a cancer (e.g., hematological malignancy) characterized by increased expression of an oncogene which is translocated with an Ig locus. Also disclosed herein are methods and assays for identifying agents that interfere with binding of bromodomain proteins to Ig regulatory elements, as well as methods and assays for identifying inhibitors of bromodomain.


Find Patent Forward Citations

Loading…